Measuring patient satisfaction with diabetes disease state management services in community pharmacy

Research in Social and Administrative Pharmacy

Volumn 5, Issue 1, 2009, Pages 31-39

  Krass, Ines ^a   Delaney, Clare ^a   Glaubitz, Susan ^b   Kanjanarach, Tipaporn ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diabetes disease state management; Measurement; Patient satisfaction; Validation

Indexed keywords

ARTICLE; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHARMACY; QUESTIONNAIRE; REPRODUCIBILITY; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICS;

DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHARMACIES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS;

EID: 61649089520     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2008.05.006     Document Type: Article

References (41)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). [comment]. Lancet 352 (1998) 837-853 [erratum appears in Lancet 1999 Aug 14;354(9178):602]
3. Gray A., Raikou M., McGuire A., et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ 320 (2000) 1373-1378
4. UK Prospective Diabetes Study (UKPDS) Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 22 (1999) 1125-1136
5. Weingarten S., Henning J., Badamgarav E., et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ 325 (2002) 1-8
6. Jaber L.A., Halapy H., Fernet M., Tummalapalli S., and Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. [comment]. Ann Pharmacother 30 (1996) 238-243
7. Davidson M.B., Karlan V.J., and Hair T.L. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual 15 (2000) 137-142
8. Irons B.K., Lenz R.J., Anderson S.L., Wharton B.L., Habeger B., and Anderson H.G.J. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy 22 (2002) 1294-1300
9. Clifford R.M., Batty K.T., Davis T.M.E., Stein G., and Stewart G. A randomized controlled trial of a pharmaceutical care programme for high-risk diabetic patients in an outpatient clinic. Int J Pharm Pract 10 (2002) 85-89
10. Rothman R.L., Malone R., Bryant B., et al. A randomized trial of primary care-based disease management program to improve cardiovascular risk factors and glycated haemoglobin levels in patients with diabetes. Am J Med 118 (2005) 276-284
11. Berringer R., Shibley M.C., Cary C.C., Pugh C.B., Powers P.A., and Rafi J.A. Outcomes of a community pharmacy-based diabetes monitoring program. [comment]. J Am Pharm Assoc 39 (1999) 791-797
12. Cranor C.W., Bunting B.A., and Christensen D.B. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 43 (2003) 73-84
13. Armour C.L., Taylor S.J., Hourihan F., Smith C., and Krass I. Implementation and evaluation of Australian pharmacists' diabetes care services. J Am Pharm Assoc 44 (2004) 455-466
14. Clifford R.M., Batty K.T., Davis W., and Davis T.M.E. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes. Diabetes Care 28 (2005) 771-776
15. Krass I., Armour C., Mitchell B., et al. The pharmacy diabetes care program: evaluating the impact of a diabetes service model delivered by community pharmacists in Australia. Diabet Med 24 (2007) 677-683
16. Bandura A. Self Efficacy: The Exercise of Control (1997), W.H. Freeman and Company, New York
17. Leventhal H., Brissette I., and Leventhal E.A. The common-sense model of self-regulation of health and illness. In: Cameron L.D., and Leventhal H. (Eds). The Self-regulation of Health and Illness Behaviour (2003), Routledge, London 42-65
18. Marquis M., Davies A., and Ware J. Patient satisfaction and change in medical care provider: a longitudinal study. Med Care 21 (1983) 821-829
19. Bartlett E., Grayson M., and Barker R. The effect of physician communication skills on patient satisfaction, recall, and adherence. J Chronic Dis 37 (1984) 744-764
20. Schommer J.C., and Kucukarslan S.N. Measuring patient satisfaction with pharmaceutical services. Am J Health Syst Pharm 54 (1997) 2721-2732
21. Malone D.C., Rascati K.L., and Gagnon J.P. Consumer's evaluation of value added pharmacy services. Amer Pharm NS33 (1993) 48-56
22. Briesacher B., and Corey R. patient satisfaction with pharmaceutical services at independent and chain pharmacies. Am J Health Syst Pharm 54 (1997) 531-536
23. Kucukarslan S.N., Pathak D.S., and Summers K. Response-oriented patient evaluation survey (ROPES): administrator's tool for identifying opportunities for service quality improvement. J Manage Care Pharm 4 (1998) 311-320
24. Gourley G.K., Gourley D.R., La Monica Rigolosi E., et al. Development and validation of the pharmaceutical care satisfaction questionnaire. Am J Manag Care 7 (2001) 461-466
25. Sansgiry S.S., and Jayawant S.S. Pharmacy patient-reported satisfaction with health care services offered by health plans, health clinics, and pharmacies. Drug Ben Trends 17 38 (2005) 40-42 45-49
26. Schommer J.C. Higher levels of consultation services increase patient satisfaction. Am Pharm NS35 (1995) 33-39
27. Schommer J.C. Roles of normative and predictive expectations in evaluation of pharmacists consultation services. J Consum Satisfac Dissatisfac Complain Behav 9 (1996) 86-94
28. Paddock L.E., Veloski J., Chatterton M.L., Gevirtz F.O., and Nash D.B. Development and validation of a questionnaire to evaluate patient satisfaction with diabetes disease management. Diabetes Care 23 (2000) 951-956
29. Donabedian A. The quality of care: how can it be assessed?. J Am Med Assoc 260 (1988) 1743-1748
30. MacKeigan L., and Larson L. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care 27 (1989) 522-536
31. Larson LN,Rovers J.P., and MacKeigan L.D. Pharmaceutical care: update of a validated instrument. J Am Pharm Assoc 42 (2002) 44-50
32. Hernandez L., Chang C.H., Cella D., Corona M., Shiomoto G., and McGuire D.B. Development and validation of the satisfaction with pharmacist scale. Pharmacotherapy 20 (2000) 837-843
33. Krass I., Taylor S.J., Smith C., and Armour C.L. The pharmacist's role in continuity of care in type 2 diabetes: an evaluation of a model. J Pharm Technol 22 (2006) 3-8
34. SPSS. Statistical Package for the Social Science for Windows, Release 11.5 (2003), SPSS Inc, Chicago
35. Holmes-Smith P., Coote L., and Cunningham E. Structural Equation Modelling: From the Fundamental to Advanced Topics (2006), School Research, Evaluation and Measurement Services, Melbourne
36. McClain AL. Hierarchical analytic methods that yield different perspectives on dynamics: aids to interpretation. In: Advances in Social Science Methodology; Vol. 3 ed. Bruce Thompson, Greenwich, Conn.; London, England 1994.
37. Arbuckle J.L. Amos 7.0 User's Guide (2006), SPSS Inc., Chicago, IL
38. Jaccard J., and Wan C.K. LISREL Approaches to Interaction Effects in Multiple Regression (1996), Sage Publications, Thousand Oaks, CA
39. Fan X., Thompson B., and Wang L. Effects of sample size, estimation method, and model specification on structural equation modeling fit indexes. Struct Equ Model 6 (1999) 56-83
40. Fornell C., and Larcker D. Structural equation models with unobservable variables and measurement error. J Mark Res 23 (1981) 439-452
41. Garver M.S., and Mentzer J.T. Logistics research methods: employing structural equation modeling to test for construct validity. J Bus Logistics 20 (1999) 33-57